U.S. Markets open in 6 hrs 43 mins

Exelixis Rises as Fourth-Quarter Earnings Beat Estimates

M. Corey Goldman

The company reports fourth-quarter earnings above analysts' forecasts amid strong revenue from collaboration agreements and royalty payments to distribute its drugs.